NCT06905262 Tumor Antigen Discovery for Innovative Cancer Immunotherapies in HCC: from Benchside to Bedside (HepAnt) Status RECRUITING Phase N/A
NCT06904170 Durvalumab and Tremelimumab With or Without Hepatic Arterial Infusion of Chemotherapy in Hepatocellular Carcinoma Status RECRUITING Phase PHASE2/PHASE3
NCT06902246 Regorafenib and Yttrium-90 Radioembolization for Unresectable Hepatocellular Carcinoma Status RECRUITING Phase PHASE2
NCT06899152 HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer Status RECRUITING Phase NA
NCT06887348 A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3 Status RECRUITING Phase N/A
NCT06880523 STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma Status RECRUITING Phase PHASE2
NCT06867432 Efficacy and Safety of Yttrium-90 Microspheres Selective Internal Radiotherapy Combined with Immune Checkpoint Inhibitors and Anti-angiogenesis Drugs Sequential HAIC for Hepatocellular Carcinoma Status NOT_YET_RECRUITING Phase PHASE2
NCT06864221 Plasma Sphingolipid Metabolites and Radiotherapy Efficacy in Hepatocellular Carcinoma Status RECRUITING Phase N/A
NCT06852820 68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC) Status RECRUITING Phase PHASE2
NCT06836778 Comparative Study of Carvedilol Monotherapy Versus Combination Therapy With Endoscopic Variceal Ligation (EVL) for Primary Prophylaxis of Variceal Bleeding in Patients With Hepatocellular Carcinoma With High-Risk Esophageal Varices Status NOT_YET_RECRUITING Phase NA
NCT06823050 A Prospective, Multicenter, Phase II Clinical Study on the Treatment of Unresectable Advanced HCC with DEB-TACE Combined with SALOX-HAIC Status NOT_YET_RECRUITING Phase N/A
NCT06819566 Prophylactic Endoscopic Variceal Ligation in Patients With High-risk Esophageal Varices Receiving Atezo/Bev for HCC Status RECRUITING Phase PHASE2
NCT06813508 Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH Status RECRUITING Phase N/A
NCT06798194 Fusing Ultrasound and Magnetic Resonance Imaging to Intelligently Plan Highly Conformal Ablation Thermal Field for Hepatocellular Carcinoma Status NOT_YET_RECRUITING Phase N/A
NCT06796114 Identification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and Durvalumab Status RECRUITING Phase NA
NCT06795022 First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours Status RECRUITING Phase PHASE1/PHASE2
NCT06789757 The Study of Atezolizumab, Bevacizumab and Memantine in Patients With Hepatocellular Carcinoma (HCC) Status RECRUITING Phase PHASE2